Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
Propionyl-L-carnitine activates Src kinase , Akt , induces p-AMPK and nitric oxide synthesis
PLoS ONE 11(2):e0148827
Published Literature Interpretation for Research Buyers Research buyers should read literature by evidence type
Moreover, traumatic brain injury or genetic defects in GABA transporter (GAT) further hinder the reuptake of GABA, diminishing inhibitory tone [41]
Repurposing of already approved drugs has been explored, for example, disulfiram, a drug traditionally used to treat alcohol dependence, can lower cystine levels in cystinotic cells, but has side effects that limit its use in cystinosis [151, 153]